MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling. - Wikidata - thesis-toulmin - TriplyDB

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

http://www.wikidata.org/entity/Q37630620

about

The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics.Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells.Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway.Current status and perspectives of genome editing technology for microalgae.Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer.Mitofusin 2: from functions to disease.and effects of hyperplasia suppressor gene on the proliferation and apoptosis of lung adenocarcinoma A549 cells

P2860

Q30252391-355424CC-8580-4B70-A6CE-9A2DE8BE3E24 Q39397584-B9B8430C-A441-4814-9E55-F294CD8A2759 Q47160638-4746AC1E-09F5-44D7-B9C0-4D26DBE6B7F6 Q47226763-E0CEDE1B-A979-494C-94A2-0B712A7D9BF3 Q54260274-D2C1A73A-D0C0-47CD-B50F-6D690A6C4F17 Q55003621-8B9026AC-F207-4A5A-88B6-B031B7C8505C Q57044372-40BE5690-5F75-41C8-92D3-3297F9177501

P2860

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

http://www.wikidata.org/entity/Q37630620

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@en

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@nl

type

label

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@en

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@nl

prefLabel

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@en

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@nl

P1433

Q37630620-5FE56CD6-F058-4C12-9DA8-312E6D30F565

P1476

Q37630620-232AE5AF-9401-49BA-B86B-8EAC024CEDE1

P2093

Q37630620-35E0A514-ED28-409A-BC1F-333C3829E4A9

Q37630620-60E87CAA-C7DE-44DA-B32A-DB2F1F646185

Q37630620-6444321C-D7F5-4099-8216-D3DDD815C2DD

Q37630620-69FCAC3C-EDD7-41A2-B069-9792457D8F55

Q37630620-96076E2C-CED5-4C88-A768-0CD801DC2110

Q37630620-BAB3FB91-942C-47D4-914A-DA4D916DE4A8

Q37630620-C0EC5634-96D1-4489-B092-7AB289ED6C58

Q37630620-CC6AD968-F6A9-4638-9F98-59297A92347E

Q37630620-DFE8CDC0-8F70-48B6-AB65-8FBCEE2CCA76

P2860

Q37630620-0CB641A3-8A33-4223-8CC5-91D3DE66CBA6

Q37630620-19FE7EEE-08C5-448C-AB73-810DAABBC4DC

Q37630620-1CEC31D1-4B4C-45C7-8155-E42D6C1B7313

Q37630620-20630F2F-184C-4D15-B823-68DB9384CB00

Q37630620-272AED24-6746-4C7A-A438-BE6E8D19F661

Q37630620-2A18B751-55A2-4846-BC44-89CF80CAF876

Q37630620-351C3BF7-8942-4267-B358-D4E6E6734D0C

Q37630620-43218520-9B81-4861-8867-265E1083E643

Q37630620-43C88ADB-04E9-4397-8225-A62020522D25

Q37630620-444DD46B-34C6-4426-A705-3BBBEA41FA0F

P2888

Q37630620-2F6297C1-62E4-4FB1-92C6-B399024B1DFF

P304

Q37630620-0B52DE5F-7A16-462F-AE49-2F82FEB98F45

P31

Q37630620-3A06B154-7D3B-4C7A-A9DF-5132640D3359

P356

Q37630620-14FF2BAC-687F-42FA-B446-717D9A58F9A0

P407

Q37630620-50D16DDE-3D03-4422-8381-4323AE531A60

P478

Q37630620-CDBD9140-FF89-4005-895E-2E4FD12FB220

P50

Q37630620-A13D429C-8543-4ED9-8A50-F4DA95C3C742

P577

Q37630620-F37438D7-EECA-4388-A336-C87AA990C996

P6179

Q37630620-82068492-513D-4A1D-8917-06262925898E

P698

Q37630620-D3F24A47-33C4-4E6B-B17E-652AA3455265

P932

Q37630620-0ABF2A45-5664-4897-B29E-EB4A0708138B

P356

P1433

Scientific Reports

P1476

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

@en

P2093

Jianhua Xu

http://www.w3.org/2001/XMLSchema#string

Ke Xu

http://www.w3.org/2001/XMLSchema#string

Lei Dong

http://www.w3.org/2001/XMLSchema#string

Peihao Yin

http://www.w3.org/2001/XMLSchema#string

Xiaobo Li

http://www.w3.org/2001/XMLSchema#string

Xiaoqin Wu

http://www.w3.org/2001/XMLSchema#string

Xin Liang

http://www.w3.org/2001/XMLSchema#string

Yu Zhu

http://www.w3.org/2001/XMLSchema#string

Zhijie Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Dysregulation of HSG triggers vascular proliferative disorders

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

mTOR: from growth signal integration to cancer, diabetes and ageing

Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology

AKT/PKB signaling: navigating downstream

Guilty as charged: B-RAF is a human oncogene

The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Epidermal growth factor receptor mutations in lung cancer

P2888

P304

41718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP41718

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083733682

http://www.w3.org/2001/XMLSchema#string

P698

28176801

http://www.w3.org/2001/XMLSchema#string

P932

5296837

http://www.w3.org/2001/XMLSchema#string